Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload

被引:190
作者
Hu, P
Zhang, DF
Swenson, L
Chakrabarti, G
Abel, ED
Litwin, SE
机构
[1] Vet Affairs Med Ctr, Div Cardiol, Salt Lake City, UT 84148 USA
[2] Univ Utah, Div Cardiol, Salt Lake City, UT 84132 USA
[3] Univ Utah, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84132 USA
[4] Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84132 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2003年 / 285卷 / 03期
关键词
hypertrophy; contractility; fibrosis;
D O I
10.1152/ajpheart.00108.2003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We developed a minimally invasive method for producing left ventricular (LV) pressure overload in mice. With the use of this technique, we quickly and reproducibly banded the transverse aorta with low surgical morbidity and mortality. Minimally invasive transverse aortic banding (MTAB) acutely and chronically increased LV systolic pressure, increased heart weight-to-body weight ratio, and induced myocardial fibrosis. We used this technique to determine whether reduced insulin signaling in the heart altered the cardiac response to pressure overload. Mice with cardiac myocyte-restricted knockout of the insulin receptor (CIRKO) have smaller hearts than wild-type (WT) controls. Four weeks after MTAB, WT and CIRKO mice had comparably increased LV systolic pressure, increased cardiac mass, and induction of mRNA for beta-myosin heavy chain and atrial natriuretic factor. However, CIRKO hearts were more dilated, had depressed LV systolic function by echocardiography, and had greater interstitial fibrosis than WT mice. Expression of connective tissue growth factor was increased in banded CIRKO hearts compared with WT hearts. Thus lack of insulin signaling in the heart accelerates the transition to a more decompensated state during cardiac pressure overload. The use of the MTAB approach should facilitate the study of the pathophysiology and treatment of pressure-overload hypertrophy.
引用
收藏
页码:H1261 / H1269
页数:9
相关论文
共 42 条
  • [21] FACTOR SM, 1981, AM J PATHOL, V102, P219
  • [22] DIABETIC CARDIOMYOPATHY
    FEIN, FS
    SONNENBLICK, EH
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (01) : 65 - 73
  • [23] Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion -: The roles of PI3-kinase, akt, and endothelial nitric oxide synthase phosphorylation
    Gao, F
    Gao, E
    Yue, TL
    Ohlstein, EH
    Lopez, BL
    Christopher, TA
    Ma, XL
    [J]. CIRCULATION, 2002, 105 (12) : 1497 - 1502
  • [24] Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs
    Jacob, A
    Molkentin, JD
    Smolenski, A
    Lohmann, SM
    Begum, N
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 283 (03): : C704 - C713
  • [25] Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease
    Jagasia, D
    Whiting, JM
    Concato, J
    Pfau, S
    McNulty, PH
    [J]. CIRCULATION, 2001, 103 (13) : 1734 - 1739
  • [26] Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism
    Jonassen, AK
    Brar, BK
    Mjos, OD
    Sack, MN
    Latchman, DS
    Yellon, DM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (05) : 757 - 764
  • [27] Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats
    Kolter, T
    Uphues, I
    Eckel, J
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (01): : E59 - E67
  • [28] Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy
    Lee, WL
    Chen, JW
    Ting, CT
    Ishiwata, T
    Lin, SJ
    Korc, M
    Wang, PH
    [J]. ENDOCRINOLOGY, 1999, 140 (10) : 4831 - 4840
  • [29] Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy
    Li, Q
    Li, BS
    Wang, XW
    Leri, A
    Jana, KP
    Liu, Y
    Kajstura, J
    Baserga, R
    Anversa, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) : 1991 - 1999
  • [30] Cytoplasmic signaling pathways that regulate cardiac hypertrophy
    Molkentin, JD
    Dorn, GW
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 2001, 63 : 391 - 426